carbamates has been researched along with amelubant in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderskewitz, R; Birke, FW; Jennewein, HM; Meade, CJ; Speck, GA | 1 |
| Alten, R; Emmerich, J; Gromnica-Ihle, E; Pohl, C; Roscher, R; Schmolke, B; Sigmund, R; Steffgen, J; Steinmann, G | 1 |
| Bäck, M; Bränström, R; Bu, DX; Hansson, GK; Sheikine, Y; Yan, ZQ | 1 |
| Schmitt-Grohé, S; Zielen, S | 1 |
| Alten, RH; Bensen, WG; Bombardieri, S; Brown, JP; de-Miquel, G; Díaz-González, F; Dougados, M; Durez, P; Leledy, C; Ortiz, P; Polmar, SH; Salin, L; Sibley, JT; Sigmund, R; Staab, A | 1 |
| Bäck, M; Brink, C; Feldman, L; Hlawaty, H; Jacob, MP; Letourneur, D; Louedec, L; Michel, JB | 1 |
| Aktürk, FF; Bilton, D; Born, T; Bragonzi, A; Cigana, C; Döring, G; Elborn, JS; Gilpin, D; Heyder, S; Kohlhäufl, M; Konstan, MW; Loebinger, MR; Paroni, M; Pier, GB; Schmidt, A; Smaczny, C; Tunney, MM; Ulrich, M; Wagner, TO | 1 |
| Bessi, VL; Bitencourt, CS; Borgeat, P; Faccioli, LH; Hamdan, L; Huynh, DN; Lefebvre, JS; Lévesque, T; Marleau, S; Ménard, L; Sohouhenou, F | 1 |
| Bhattacharya, S; Döring, G; Hamilton, A; Heltshe, SL; Hilliard, KA; Koker, P; Konstan, MW; Lands, LC; Staab, A | 1 |
| Bäck, M; Hermansson, A; Hlawaty, H; Ketelhuth, DF; Letourneur, D; Yan, ZQ | 1 |
1 review(s) available for carbamates and amelubant
| Article | Year |
|---|---|
Leukotriene receptor antagonists in children with cystic fibrosis lung disease : anti-inflammatory and clinical effects.
Topics: Adolescent; Amidines; Asthma; Bronchial Hyperreactivity; Carbamates; Child; Child, Preschool; Clinical Trials as Topic; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Inflammation Mediators; Leukotriene Antagonists; Neutrophils; Respiratory Tract Infections; Virus Diseases | 2005 |
3 trial(s) available for carbamates and amelubant
| Article | Year |
|---|---|
Inhibition of leukotriene B4-induced CD11B/CD18 (Mac-1) expression by BIIL 284, a new long acting LTB4 receptor antagonist, in patients with rheumatoid arthritis.
Topics: Adolescent; Adult; Aged; Amidines; Area Under Curve; Arthritis, Rheumatoid; Carbamates; Double-Blind Method; Female; Humans; Leukotriene Antagonists; Leukotriene B4; Macrophage-1 Antigen; Male; Middle Aged; Neutrophils; Time Factors | 2004 |
Clinical trial of a leucotriene B4 receptor antagonist, BIIL 284, in patients with rheumatoid arthritis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amidines; Arthritis, Rheumatoid; Carbamates; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Receptors, Leukotriene B4; Treatment Outcome | 2007 |
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Topics: Adolescent; Adult; Amidines; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Carbamates; Child; Cystic Fibrosis; Disease Progression; Double-Blind Method; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Early Termination of Clinical Trials; Female; Humans; Inflammation; Male; Receptors, Leukotriene B4; Respiratory Function Tests; Risk Assessment; Sputum; Treatment Outcome | 2014 |
6 other study(ies) available for carbamates and amelubant
| Article | Year |
|---|---|
In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B(4) receptor antagonist.
Topics: Amidines; Animals; Anti-Inflammatory Agents; Benzoates; Calcium; Carbamates; Cell Line; Chemotaxis, Leukocyte; Guinea Pigs; Humans; Leukotriene B4; Macrophage-1 Antigen; Neutrophils; Rabbits; Rats; Receptors, Leukotriene B4; Species Specificity; Succinates | 2001 |
Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia.
Topics: Amidines; Analysis of Variance; Animals; Atherosclerosis; Blotting, Western; Carbamates; Carotid Artery Injuries; Cell Movement; Electrophysiology; Fatty Alcohols; Glycols; Humans; Hyperplasia; Leukotriene B4; Male; Muscle, Smooth, Vascular; NF-kappa B; Patch-Clamp Techniques; Polymerase Chain Reaction; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Leukotriene B4; Receptors, Purinergic P2; Signal Transduction; Tunica Intima; Up-Regulation | 2005 |
Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
Topics: Administration, Oral; Amidines; Angioplasty, Balloon; Animals; Carbamates; Carotid Artery, Common; Carotid Stenosis; Cell Line; Cell Movement; Cell Proliferation; Cholesterol, Dietary; Disease Models, Animal; Extracellular Matrix; Humans; Hyperplasia; Leukotriene Antagonists; Leukotriene B4; Macrophages; Male; Mammary Arteries; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Organ Culture Techniques; Rabbits; RNA Interference; RNA, Small Interfering; Secondary Prevention; Stents; Time Factors; Transfection | 2009 |
BIIL 284 reduces neutrophil numbers but increases P. aeruginosa bacteremia and inflammation in mouse lungs.
Topics: Adult; Amidines; Animals; Anti-Inflammatory Agents; Bacteremia; Carbamates; Cystic Fibrosis; Disease Models, Animal; Female; Humans; Inflammation; Leukocyte Count; Lung; Male; Mice; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Receptors, Leukotriene B4; Treatment Outcome | 2014 |
Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.
Topics: Amidines; Animals; Azepines; Biological Assay; Carbamates; Dermis; Disease Models, Animal; Extravasation of Diagnostic and Therapeutic Materials; Extremities; Inflammation; Leukotriene B4; Leukotrienes; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Neutrophil Infiltration; Platelet Activating Factor; Platelet Membrane Glycoproteins; Propionates; Quinolines; Rabbits; Receptors, G-Protein-Coupled; Receptors, Leukotriene; Reperfusion Injury; Triazoles | 2013 |
The leukotriene B4 receptor (BLT) antagonist BIIL284 decreases atherosclerosis in ApoE-/- mice.
Topics: Amidines; Animals; Apolipoproteins E; Atherosclerosis; Carbamates; Cytokines; Male; Matrix Metalloproteinases; Mice; Receptors, Leukotriene B4; RNA, Messenger; Signal Transduction; Tissue Inhibitor of Metalloproteinases | 2015 |